A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: wheel (17), pedals (5)

InP- VTD PACE (SC) Bortezomib (SC) Cisplatin Cyclophosphamide Dexamethasone Doxorubicin Etoposide Thalidomide

Description
Chemotherapy Protocol MULTIPLE MYELOMA VTD-PACE (SC)-BORTEZOMIB (SC)-CISPLATIN-CYCLOPHOSPHAMIDEDEXAMETHASONE-DOXORUBICIN-ETOPOSIDE-THALIDOMIDE (VTD-PACE SC) In-Patient Regimen There
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/InP-VTD-PACE-SC-Bortezomib-SC-Cisplatin-Cyclophosphamide-Dexamethasone-Doxorubicin-Etoposide-Thalidomide.pdf

Nivolumab Ver 1.1 skin

Description
Chemotherapy Protocol SKIN CANCER Nivolumab This regimen may require funding. Regimen Skin – Nivolumab Indication The treatment of advanced (unresectable or metastatic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/NivolumabVer1.1.pdf

Nivolumab 480mg skin

Description
Chemotherapy Protocol SKIN CANCER Nivolumab (480mg-28 days) Regimen • Skin – Nivolumab (480mg-28 days) Indication • Nivolumab is recommended, within its marketing
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Nivolumab-480mg.pdf

Nivolumab 240mg skin

Description
Chemotherapy Protocol SKIN CANCER Nivolumab (240mg-14 days) Regimen • Skin – Nivolumab (240mg-14 days) Indication • Nivolumab is recommended, within its marketing
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Nivolumab-240mg.pdf

Ipilimumab-Nivolumab

Description
Chemotherapy Protocol SKIN CANCER IPILIMUMAB (3mg/kg)-NIVOLUMAB (1mg/kg) Regimen • Skin – Ipilimumab (3mg/kg)-Nivolumab (1mg/kg) Indication • Ipilimumab in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Ipilimumab-Nivolumab.pdf

Dabrafenib Ver 1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for the first line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Ipilimumab-Nivolumab Ver1

Description
Chemotherapy Protocol MESOTHELIOMA IPILIMUMAB-NIVOLUMAB Regimen • Mesothelioma – Ipilimumab-Nivolumab Indication • Nivolumab in combination with ipilimumab is indicated for the first-line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/Ipilimumab-Nivolumab-Ver1.pdf

Current funding calls

Description
Auto Generated Title Here you can find new grant funding calls from various funders. Links on the right will take you
Url
/ClinicalResearchinSouthampton/For-researchers/Grant-funding-support/Current-funding-calls/Current-funding-calls.aspx

CH001 SOP protocol verification

Description
Standard Operating Procedure Production of Chemotherapy Protocols (SOP:CH001) 1. Objective 1.1 The purpose of this standard operating procedure (SOP
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH001SOP-protocol-verification.pdf

Cystic fibrosis diabetes - patient information

Description
This factsheet explains what to expect when you are tested for cystic fibrosis diabetes (CFD).
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Cystic-fibrosis-diabetes-2635-PIL.pdf
251 to 260 of 1000
Previous … 24 25 26 27 28 … Next